Study of the cardiac alterations in HIV-infected children consequent to the antiretroviral therapy. Prospective study of 47 cases;Estudo das alterações cardíacas em crianças com SIDA em relação à terapêutica com anti-retrovirais. Estudo prospectivo de 47 casos

Arquivos Brasileiros de Cardiologia

Volumn 80, Issue 3, 2003, Pages 311-320

  Herdy, Gesmar Volga Haddad ^a,b   Pinto, Carlos Alberto M ^a   Lopes, Vania Gloria S ^a   Ribeiro, Raquel P ^a   Gomes, Ivete Martins ^a   Tchou, Hsu Y ^a   Melo, Renata ^a   Kurdian, Bedros ^a   De Assis Tavares Jr , Plínio ^a  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b Trav Antonio Pedro   (Brazil)

Author keywords

AIDS; Children; Heart

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CADAVER; CARDIOMYOPATHY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; HEART ARRHYTHMIA; HEART DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALNUTRITION; PERICARDIAL EFFUSION; PROSPECTIVE STUDY; TACHYCARDIA; THORAX RADIOGRAPHY;

EID: 17144433344     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0066-782X2003000300007     Document Type: Article

References (32)

1. Brasil, Ministério da Saúde, Divisão de DST/AIDS. AIDS. Boletim Epidemiológico, ano XI, n° 3, junho a agosto de 1998.
2. Herdy GVH, Leite MM, Lopes VGS, Pinto CAM. Alterações cardíacas em crianqas com SIDA. Arq Bras Cardiol 1997; 68: 274-7.
3. Connor E, Spering RS, Geller R, et al. Reduction of maternal-infant transmission of HIV-1 with zidovudine treatment. N Eng J Med 1994; 331: 1173-9.
4. Center for Disease Control and Prevention (CDC). Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 1998; 47 (RR4): 1-31.
5. Lambert LS, Moye J. Current issues in the immunoprophylaxis of vertical transmission of HIV. BioDrugs 1999; 11: 31-41.
6. Lipshult SE, Easley MS, Orav J, et al. Cardiac dysfunction and mortality in HIV infected children. The prospective P2 C2 HIV multicenter study. Circulation 2000; 102: 1542-8.
7. Brasil, Ministério da Sadde, Divisão de DST/AIDS. AIDS consenso sobre terapia anti-retroviral para crianças infectadas pelo HIV. 2001; ano XIII: 1-33.
8. Center for Disease Control and Prevention (CDC). Revised classification system of human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43 (RR12): 1-10.
9. th ed. Philadelphia. WB Saunders Co, 1997: 53-98.
10. Nogueira G, Macedo AJ, Paixão A, et al. Cardiovascular morbidity in children with HIV infections. Acta Med Port 1998; 11: 1051-7.
11. Langston C, Cooper ER, Goldfarb J, et al. HIV related mortality in infants and children: data from the pediatrics pulmonary and cardiovascular complications of vertically transmitted HIV (P2 C2) study. Pediatrics 2001: 107: 328-38.
12. Mofenson LM. Epidemiology and determinants of vertical HIV transmission. Sem Ped Infect Dis 1994; 5: 252-65.
13. Abrams E, Steketee RW. Association of HIV load early in life with disease progress on among HIV infected infants, J Infec Dis 1998; 178: 101-8.
14. American Academy of Pediatrics. Disclosure of illness status to children and adolescents with HIV infection, Pediatrics 1999; 103: 64-6.
15. Lipshultz S, Fox C, Perez Atayde A. Identification ofHIV-I RNA and DNA in the heart and congenital AIDS. Am J Cardiol 1990; 66: 248-501.
16. Domanski MJ, Sloas MM, Follman DA, et al. Effect of zidovudine and didanosine treatment on heart function in children infected with HIV. Paediatrics 1995; 127: 137-46.
17. Barbaro G. Cardiovascular manifestations of HIV in fection. J RS Medicine 2001; 94: 384-90.
18. Beck MA, Kolbcck AC, Shi Q, et al. Increased virulence of a human enterovirus (Coxsackie B3) in selenium-deficieney mice. J Infect Dis 1994; 170: 351-7.
19. Kaul S, Fishbeim MC, Siegel R. Cardiac manifestations ofAIDS. A 1991 update. Am Heart J 1991; 122: 535-44.
20. Herdy GVH, Ramos R, Bazin AR, et al. Correlação clinico-patológica de 50 casos de SIDA. Estudo retrospectivo. Arq Bras Cardiol 1994; 60: 95-8.
21. a Ed. Rio de Janeiro: Guanabara, 1998: 982-5.
22. Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Ann Intern Med 1990; 113: 227-42.
23. Ognibene FP, Parker MM, Natanson C, al. Depressed left ventricular performance: response to volume infunsion in patients with sepsis. Chest 1998; 93: 903-10.
24. Barbaro G, Di Lorenzo G, Grisorio B, Barbarini G and Gruppo italiano per 1o studio cardiológico dei pazienti affeti da AIDS investigators. Cardiac involvement in the AIDS. A multicenter clinical-pathological study. AIDS Res Hum Retroviruses. 1998; 14: 1071-7.
25. Barbaro G, Di Lorenzo G, Soldini M, et al. The intensity of myocardial expression of inducible nitric oxide synthesis influences the course of human immunoficiency virus associated. cardiomyopathy Circulation 1999; 199: 633-9.
26. Rerkpattanapipat P, Jacobs LE, Kotler MN. Cardiac manifestations of AIDS. Arch Int Med 2000; 160: 602-8.
27. Butler K. Pediatric human imnmnodeficiency virus infection. In: "Gorbach-Batlet-Blacklow Infectious Diseases. Cap 140. Saunders Co: Philadelphia, 1992: 1005-20.
28. Valentine M, Jackson C, Vavro C, et al. Evaluation of surrogate and clinical outcome in two years follow-up of 86 HIV pediatric patients. Ped J Infect Dis 1998; 17: 18-23.
29. Shearer WT, Quinn TC, Larussa P, et al. Viral load and disease progression in infants infected with HIV type 1. N Engl J Med 1997; 336: 1337-42.
30. Gullestad L, Aass H, Fjeld JG, et al. Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure. Circulation 2001; 103: 220-5.
31. Karpas K, Hill M, Youle M. Polymerase chain reaction evidence for HIV-1 neutralization by passive immunization in patients with AIDS. Proc Natl Acad Sci USA 1990; 87: 7613-7.
32. Vejkovic V, Metlas R, Jevtovic D, et al. The role of passive immunization in HIV positive patients. Chest 2001; 120: 661-6.